查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1789207

蛋白质治疗市场分析及预测（至2034年）：类型、产品、技术、应用、最终用户、形式、流程、安装类型、设备

Protein Therapeutics Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Form, Process, Installation Type, Equipment
出版日期: | 出版商: Global Insight Services | 英文 494 Pages | 商品交期: 3-5个工作天内

价格
简介目录

蛋白质疗法市场预计将从2024年的3,760亿美元增加到2034年的7,408亿美元，复合年增长率约为7%。蛋白质疗法市场包括基于生物衍生蛋白质的治疗方法，用于治疗各种病症。该市场涵盖单株抗体、疫苗和肽激素，可提供高度特异性的标靶治疗。慢性病的增加和生物技术的进步正在推动市场成长，蛋白质工程和递送系统的创新提高了治疗效果和患者预后。监管支持和医疗支出的增加将进一步推动市场扩张。

全球关税和地缘政治紧张局势对蛋白质治疗市场产生了重大影响，尤其是在东亚地区。日本和韩国正在策略性地投资生物製药创新，以减少对进口的依赖并抵消关税的影响。中国大陆在出口限制的背景下，正加速提升其生物製药能力，同时注重自给自足。儘管存在地缘政治脆弱性，但台湾仍发挥重要参与企业，利用其先进的製造业。在生技药品和个人化医疗的推动下，全球蛋白质治疗市场表现强劲。在区域合作和生物相似药创新的推动下，预计到 2035 年市场将持续成长。中东衝突加剧了能源价格波动，可能扰乱製造业和物流业，从而间接影响了该市场，凸显了製定有弹性的供应链策略的必要性。

市场区隔
类型 单株抗体、胰岛素、红血球生成素、干扰素、集落刺激因子、生长激素、凝血因子、酵素替代
产品 治疗性蛋白质、疫苗、肽激素、血液因子
科技 重组DNA技术、融合瘤技术、基因改造技术、细胞培养
目的 癌症、代谢性疾病、血液疾病、自体免疫疾病、感染疾病、神经系统疾病
最终用户 医院、诊所、科研院所、生物製药公司
剂型 注射、口服、吸入、局部
製造方法 纯化、配製和冻干
安装类型 内部、委託
装置 反应器、层析法系统、过滤系统

受生物技术进步和慢性病发病率上升的推动，蛋白质治疗市场正经历强劲成长。单株抗体领域因其在治疗各种疾病方面的特异性和有效性而处于领先地位。在这一领域中，癌症和自体免疫疾病表现最佳，反映了其巨大的治疗潜力。治疗性蛋白质领域紧随其后，因为酵素和荷尔蒙在治疗代谢和荷尔蒙失调方面至关重要。

融合蛋白因其疗效较佳、副作用较少而日益受到欢迎，尤其是在肿瘤学和感染疾病。由于成本效益的提升以及多种生技药品专利到期，对生物相似药的需求不断增长，这为市场相关人员提供了丰厚的机会。药物输送系统和个人化医疗的创新进一步推动了市场的发展。策略伙伴关係和研发投资对于抓住新机会并在这个动态环境中保持竞争优势至关重要。

蛋白质疗法市场的特点是市场占有率多元化，定价受技术进步和策略联盟的影响而动态变化。近期上市的产品正在推动市场发展，体现了技术创新，并满足了尚未满足的医疗需求。主要参与企业正积极拓展产品组合，提高疗效，并瞄准细分市场。市场正朝着个人化医疗的方向转变，推动了对新型蛋白质疗法的需求。虽然北美仍占据主导地位，但新兴国家也提供了成长机会。

竞争性基准化分析揭示了竞争对手之间既有竞争又有策略联盟的格局。各公司正利用最尖端科技来获取竞争优势。监管影响起着关键作用，北美和欧洲的严格指导方针塑造着市场动态。法规环境在确保病人安全的同时促进创新。新兴市场正在适应全球标准，这既带来了挑战，也带来了机会。科学进步和不断增加的医疗保健投资使市场走上了成长轨道。高昂的开发成本和复杂的监管途径等挑战依然存在，但突破性治疗方法的潜力仍然巨大。

由于医疗成本上涨和慢性病的盛行，亚太地区的市场正在快速扩张。中国和印度等国家凭藉其庞大的患者群体和对新型疗法日益增长的需求，正成为一个利润丰厚的市场。拉丁美洲、中东和非洲地区也正在推动这一成长。在拉丁美洲，医疗服务可近性和基础设施的改善正在推动市场潜力的释放；而在中东和非洲，对生物技术和医疗保健进步的投资不断增加，也正在推动这一成长。

罗氏的另一项重要倡议是收购了一家前景光明的生物技术公司，该公司专注于开发新型蛋白质疗法。此次收购增强了罗氏的产品组合，并使其能够获得创新的候选疗法，以满足多个治疗领域尚未满足的医疗需求。

百健（Biogen）在监管方面也取得了重大进展，其中包括 FDA 授予其开发的用于治疗罕见遗传疾病的突破性蛋白质疗法快速通道资格。这项监管里程碑凸显了蛋白质疗法在治疗复杂疾病的潜力。

同时，辉瑞透过推出针对流行慢性疾病的尖端蛋白质疗法，对其现有产品组合产生了重大影响，其创新的作用机制有望推动市场大幅成长。

最后，两家领先的製药公司宣布成立一家专注于开发下一代蛋白质疗法的合资企业。此次合作旨在利用先进技术开发更有效、更有针对性的治疗方法，彰显了蛋白质疗法市场的持续发展与活力。

主要趋势和驱动因素

受生物技术进步和慢性疾病激增的推动，蛋白质疗法市场正经历强劲成长。生物製药创新正在推动新型蛋白质治疗方法的开发，从而提高治疗效果和患者预后。这些治疗方法由于比传统药物具有更高的特异性和更少的副作用，正日益受到欢迎。

一个关键趋势是单株抗体的扩张，因其针对癌症和自体免疫疾病的靶向作用而日益受到欢迎。由于专利到期以及对经济高效的替代品的需求，对生物相似药的需求也在增长。促进生物相似药核准和市场准入的法律规范也支持了这一趋势。

此外，个人化医疗正成为关键驱动力，蛋白质疗法在根据个人基因特征客製化治疗方案方面发挥关键作用。研发投入正在推动创新，生技公司与学术机构之间的合作正在加速药物研发进程。精准医疗和标靶治疗的日益受到重视，为蛋白质疗法创造了丰厚的机会，预计将在未来几年推动市场大幅扩张。

限制与挑战

蛋白质疗法市场面临许多重大限制与挑战。其中一项突出的挑战是高昂的开发和生产成本，这加重了製造商和消费者的经济负担。监管障碍进一步加剧了市场准入的复杂性，因为严格的合规要求需要大量的时间和资源。智慧财产权问题也构成了障碍，专利到期加剧了来自生物相似药的竞争。此外，蛋白质疗法的复杂性需要先进的仓储和配送基础设施，这增加了物流挑战和成本。最后，由于价格高昂和报销问题导致患者难以获得药物，这尤其限制了市场的发展。总而言之，这些因素阻碍了蛋白质疗法市场的成长和可及性。

目录

第一章 蛋白质治疗市场概述

  • 调查目的
  • 蛋白质治疗市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章：蛋白质治疗市场展望

  • 蛋白质治疗市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章：蛋白质治疗市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 使用案例分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析

第六章：蛋白质治疗市场规模

  • 蛋白质治疗市场规模（按价值）
  • 蛋白质治疗市场规模（按数量）

第七章蛋白质治疗市场规模（按类型）

  • 市场概览
  • 单株抗体
  • 胰岛素
  • 促红血球生成素
  • 干扰素
  • 集落刺激因子
  • 生长激素
  • 凝血因子
  • 酵素补充剂
  • 其他的

8. 蛋白质治疗市场（按产品）

  • 市场概览
  • 治疗性蛋白质
  • 疫苗
  • 肽激素
  • 血液因素
  • 其他的

9. 蛋白质治疗市场（依技术）

  • 市场概览
  • 重组DNA技术
  • 融合瘤技术
  • 基因改造技术
  • 细胞培养
  • 其他的

第 10 章：蛋白质治疗市场（按应用）

  • 市场概览
  • 癌症
  • 代谢紊乱
  • 血液疾病
  • 自体免疫疾病
  • 感染疾病
  • 神经系统疾病
  • 其他的

第 11 章：蛋白质治疗市场（以最终用户划分）

  • 市场概览
  • 医院
  • 诊所
  • 研究所
  • 生物製药公司
  • 其他的

第 12 章：蛋白质治疗市场（按形式）

  • 市场概览
  • 注射
  • 口服
  • 吸入
  • 外用药物
  • 其他的

第 13 章：蛋白质治疗市场（按工艺）

  • 市场概览
  • 纯化
  • 配方
  • 冷冻干燥
  • 其他的

第 14 章。蛋白质治疗市场（按安装类型）

  • 市场概览
  • 内部
  • 委託
  • 其他的

第 15 章。蛋白质治疗市场（按设备）

  • 市场概览
  • 反应器
  • 层析法系统
  • 过滤系统
  • 其他的

第 16 章：蛋白质治疗市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市场占有率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • QuidelOrtho
  • Bio-Rad Laboratories
  • Cepheid
  • BioMerieux
  • Hologic
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Beckman Coulter
  • Nova Biomedical
  • Alere
  • Randox Laboratories
  • Sekisui Diagnostics
  • Trinity BIoTech
  • Meridian Bioscience
  • EKF Diagnostics
  • Luminex Corporation
简介目录
Product Code: GIS33198

Protein Therapeutics Market is anticipated to expand from $376.0 Billion in 2024 to $740.8 Billion by 2034, growing at a CAGR of approximately 7%. The Protein Therapeutics Market encompasses biologically-derived treatments using proteins to address various medical conditions. This market includes monoclonal antibodies, vaccines, and peptide hormones, offering targeted therapies with high specificity. The increasing prevalence of chronic diseases and advancements in biotechnology fuel market growth, with innovations in protein engineering and delivery systems enhancing therapeutic efficacy and patient outcomes. Regulatory support and rising healthcare expenditures further bolster market expansion.

Global tariffs and geopolitical tensions are profoundly influencing the Protein Therapeutics Market, particularly in East Asia. Japan and South Korea are strategically investing in biopharmaceutical innovation to mitigate reliance on imports and counter tariff impacts. China is accelerating its biopharma capabilities, focusing on self-sufficiency amidst export restrictions, while Taiwan leverages its advanced manufacturing to remain a pivotal player despite geopolitical vulnerabilities. The global protein therapeutics market is robust, driven by advancements in biologics and personalized medicine. By 2035, growth is anticipated to be sustained through regional collaborations and innovation in biosimilars. Middle East conflicts indirectly affect this market by exacerbating energy price volatility, which could disrupt manufacturing and logistics, highlighting the need for resilient supply chain strategies.

Market Segmentation
TypeMonoclonal Antibodies, Insulin, Erythropoietin, Interferons, Colony Stimulating Factors, Growth Hormones, Coagulation Factors, Enzyme Replacement
ProductTherapeutic Proteins, Vaccines, Peptide Hormones, Blood Factors
TechnologyRecombinant DNA Technology, Hybridoma Technology, Transgenic Technology, Cell Culture
ApplicationCancer, Metabolic Disorders, Blood Disorders, Autoimmune Diseases, Infectious Diseases, Neurological Disorders
End UserHospitals, Clinics, Research Institutes, Biopharmaceutical Companies
FormInjectable, Oral, Inhalable, Topical
ProcessPurification, Formulation, Lyophilization
Installation TypeIn-House, Outsourced
EquipmentBioreactors, Chromatography Systems, Filtration Systems

The Protein Therapeutics Market is experiencing robust growth, driven by advancements in biotechnology and increasing prevalence of chronic diseases. The monoclonal antibodies segment leads in performance, due to their specificity and effectiveness in treating various conditions. Within this segment, cancer and autoimmune diseases are top-performing sub-segments, reflecting their significant therapeutic potential. The therapeutic proteins segment follows closely, with enzymes and hormones being pivotal in addressing metabolic and hormonal disorders.

Fusion proteins are also gaining traction, particularly in oncology and infectious diseases, offering enhanced efficacy and reduced side effects. The demand for biosimilars is rising, driven by cost-effectiveness and the expiration of patents for several biologics, providing lucrative opportunities for market players. Innovations in drug delivery systems and personalized medicine are further propelling the market. Strategic collaborations and investments in R&D are crucial for capturing emerging opportunities and sustaining competitive advantage in this dynamic landscape.

The Protein Therapeutics Market is characterized by diverse market share, with a dynamic pricing landscape influenced by technological advancements and strategic alliances. Recent product launches have invigorated the market, reflecting innovation and a focus on addressing unmet medical needs. Key players are actively engaged in expanding their portfolios, enhancing therapeutic efficacy, and targeting niche segments. The market is witnessing a shift towards personalized medicine, driving demand for novel protein-based therapies. North America remains a dominant force, while emerging economies present lucrative opportunities for growth.

Competition benchmarking reveals a landscape marked by intense rivalry and strategic collaborations. Companies are leveraging cutting-edge technologies to gain competitive advantages. Regulatory influences play a pivotal role, with stringent guidelines in North America and Europe shaping market dynamics. The regulatory environment fosters innovation while ensuring patient safety. Emerging markets are adapting to global standards, presenting both challenges and opportunities. The market's trajectory is poised for growth, driven by scientific advancements and increasing healthcare investments. Challenges such as high development costs and complex regulatory pathways persist, yet the potential for groundbreaking therapies remains substantial.

Geographical Overview:

The protein therapeutics market is witnessing robust growth across various regions, each presenting unique opportunities. North America remains at the forefront, driven by advanced healthcare infrastructure and significant R&D investments. The presence of key industry players further bolsters the region's market dominance. Europe follows closely, with strong government support and a focus on biopharmaceutical innovation enhancing market prospects. The region's emphasis on personalized medicine and biotechnology fuels growth.

In the Asia-Pacific region, the market is expanding rapidly due to increasing healthcare expenditures and a growing prevalence of chronic diseases. Countries like China and India are emerging as lucrative markets, owing to their large patient populations and rising demand for novel therapies. Latin America and the Middle East & Africa are also gaining traction. In Latin America, improvements in healthcare access and infrastructure drive market potential, while the Middle East & Africa benefit from increased investments in biotechnology and healthcare advancements.

Recent Developments:

The protein therapeutics market has experienced noteworthy developments over the past three months. Amgen announced a strategic collaboration with a leading biotech firm to enhance its protein engineering capabilities, aiming to accelerate drug discovery and development processes. This partnership is expected to significantly bolster Amgen\u2019s position in the protein therapeutics landscape.

In another significant move, Roche acquired a promising biotech company specializing in the development of novel protein-based therapies. This acquisition is set to enhance Roche\u2019s portfolio, providing access to innovative therapeutic candidates poised to address unmet medical needs across various therapeutic areas.

Regulatory advancements have also been prominent, with the FDA granting fast-track designation to a groundbreaking protein therapeutic developed by Biogen, aimed at treating a rare genetic disorder. This regulatory milestone underscores the potential of protein therapeutics in addressing complex medical conditions.

Meanwhile, Pfizer unveiled a cutting-edge protein therapeutic targeting a prevalent chronic disease, marking a significant addition to its existing product lineup. The launch is anticipated to drive substantial market growth, given the therapeutic\u2019s innovative mechanism of action.

Lastly, a joint venture between two pharmaceutical giants was announced, focusing on the development of next-generation protein therapeutics. This collaboration aims to leverage advanced technologies to create more effective and targeted therapies, highlighting the ongoing evolution and dynamism within the protein therapeutics market.

Key Trends and Drivers:

The Protein Therapeutics Market is experiencing robust growth, driven by advancements in biotechnology and a surge in chronic disease prevalence. Biopharmaceutical innovations are leading to the development of novel protein-based therapies, enhancing treatment efficacy and patient outcomes. These therapies are increasingly favored due to their specificity and reduced side effects compared to traditional pharmaceuticals.

A key trend is the expansion of monoclonal antibodies, which are gaining traction for their targeted action against cancer and autoimmune diseases. The market is also witnessing a rise in demand for biosimilars, driven by the expiration of patents and the need for cost-effective alternatives. This trend is further supported by regulatory frameworks that facilitate biosimilar approvals, expediting market entry.

Additionally, personalized medicine is emerging as a significant driver, with protein therapeutics playing a crucial role in tailoring treatments to individual genetic profiles. Investments in research and development are fostering innovation, while collaborations between biotech firms and academic institutions are accelerating discovery processes. The growing emphasis on precision medicine and targeted therapies is creating lucrative opportunities in the protein therapeutics landscape, promising substantial market expansion in the coming years.

Restraints and Challenges:

The protein therapeutics market is confronted with several significant restraints and challenges. One prominent challenge is the high cost of development and production, which increases the financial burden on manufacturers and consumers. Regulatory hurdles further complicate market entry, as stringent compliance requirements demand substantial time and resources. Intellectual property issues also present a barrier, with patent expirations leading to increased competition from biosimilars. Additionally, the complex nature of protein therapeutics necessitates advanced storage and distribution infrastructure, adding logistical difficulties and costs. Finally, limited patient access due to high prices and reimbursement issues restricts market expansion, particularly in developing regions. These factors collectively impede the growth and accessibility of the protein therapeutics market.

Key Companies:

Biocon, Sangamo Therapeutics, AbCellera Biologics, MacroGenics, Adaptimmune Therapeutics, BioNTech, CureVac, ImmunoGen, Kymab, Morphic Therapeutic, Pieris Pharmaceuticals, Sorrento Therapeutics, Argenx, Aptevo Therapeutics, Alector, Zymeworks, Allakos, Gritstone Oncology, Gossamer Bio, Harpoon Therapeutics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Protein Therapeutics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Protein Therapeutics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Form
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Installation Type
  • 2.11 Key Highlights of the Market, by Equipment
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Form
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Installation Type
  • 3.10 Market Attractiveness Analysis, by Equipment
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Protein Therapeutics Market Outlook

  • 4.1 Protein Therapeutics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Protein Therapeutics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Protein Therapeutics Market Size

  • 6.1 Protein Therapeutics Market Size, by Value
  • 6.2 Protein Therapeutics Market Size, by Volume

7: Protein Therapeutics Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Insulin
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Erythropoietin
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Interferons
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Colony Stimulating Factors
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Growth Hormones
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Coagulation Factors
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Enzyme Replacement
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Protein Therapeutics Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Proteins
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Vaccines
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Peptide Hormones
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Blood Factors
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Protein Therapeutics Market, by Technology

  • 9.1 Market Overview
  • 9.2 Recombinant DNA Technology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Hybridoma Technology
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Transgenic Technology
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Cell Culture
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Protein Therapeutics Market, by Application

  • 10.1 Market Overview
  • 10.2 Cancer
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Metabolic Disorders
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Blood Disorders
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Autoimmune Diseases
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Infectious Diseases
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Neurological Disorders
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Protein Therapeutics Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Research Institutes
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Biopharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Protein Therapeutics Market, by Form

  • 12.1 Market Overview
  • 12.2 Injectable
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Oral
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Inhalable
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Topical
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Protein Therapeutics Market, by Process

  • 13.1 Market Overview
  • 13.2 Purification
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Formulation
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Lyophilization
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Protein Therapeutics Market, by Installation Type

  • 14.1 Market Overview
  • 14.2 In-House
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Outsourced
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Protein Therapeutics Market, by Equipment

  • 15.1 Market Overview
  • 15.2 Bioreactors
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Chromatography Systems
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Filtration Systems
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Protein Therapeutics Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Technology
    • 16.2.5 North America Market Size and Forecast, by Application
    • 16.2.6 North America Market Size and Forecast, by End User
    • 16.2.7 North America Market Size and Forecast, by Form
    • 16.2.8 North America Market Size and Forecast, by Process
    • 16.2.9 North America Market Size and Forecast, by Installation Type
    • 16.2.10 North America Market Size and Forecast, by Equipment
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Technology
      • 16.2.9.4 United States Market Size and Forecast, by Application
      • 16.2.9.5 United States Market Size and Forecast, by End User
      • 16.2.9.6 United States Market Size and Forecast, by Form
      • 16.2.9.7 United States Market Size and Forecast, by Process
      • 16.2.9.8 United States Market Size and Forecast, by Installation Type
      • 16.2.9.9 United States Market Size and Forecast, by Equipment
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Technology
      • 16.2.10.4 Canada Market Size and Forecast, by Application
      • 16.2.10.5 Canada Market Size and Forecast, by End User
      • 16.2.10.6 Canada Market Size and Forecast, by Form
      • 16.2.10.7 Canada Market Size and Forecast, by Process
      • 16.2.10.8 Canada Market Size and Forecast, by Installation Type
      • 16.2.10.9 Canada Market Size and Forecast, by Equipment
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Technology
    • 16.3.5 Europe Market Size and Forecast, by Application
    • 16.3.6 Europe Market Size and Forecast, by End User
    • 16.3.7 Europe Market Size and Forecast, by Form
    • 16.3.8 Europe Market Size and Forecast, by Process
    • 16.3.9 Europe Market Size and Forecast, by Installation Type
    • 16.3.10 Europe Market Size and Forecast, by Equipment
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Form
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Installation Type
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Equipment
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Technology
      • 16.3.10.4 Germany Market Size and Forecast, by Application
      • 16.3.10.5 Germany Market Size and Forecast, by End User
      • 16.3.10.6 Germany Market Size and Forecast, by Form
      • 16.3.10.7 Germany Market Size and Forecast, by Process
      • 16.3.10.8 Germany Market Size and Forecast, by Installation Type
      • 16.3.10.9 Germany Market Size and Forecast, by Equipment
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Technology
      • 16.3.11.4 France Market Size and Forecast, by Application
      • 16.3.11.5 France Market Size and Forecast, by End User
      • 16.3.11.6 France Market Size and Forecast, by Form
      • 16.3.11.7 France Market Size and Forecast, by Process
      • 16.3.11.8 France Market Size and Forecast, by Installation Type
      • 16.3.11.9 France Market Size and Forecast, by Equipment
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Technology
      • 16.3.12.4 Spain Market Size and Forecast, by Application
      • 16.3.12.5 Spain Market Size and Forecast, by End User
      • 16.3.12.6 Spain Market Size and Forecast, by Form
      • 16.3.12.7 Spain Market Size and Forecast, by Process
      • 16.3.12.8 Spain Market Size and Forecast, by Installation Type
      • 16.3.12.9 Spain Market Size and Forecast, by Equipment
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Technology
      • 16.3.13.4 Italy Market Size and Forecast, by Application
      • 16.3.13.5 Italy Market Size and Forecast, by End User
      • 16.3.13.6 Italy Market Size and Forecast, by Form
      • 16.3.13.7 Italy Market Size and Forecast, by Process
      • 16.3.13.8 Italy Market Size and Forecast, by Installation Type
      • 16.3.13.9 Italy Market Size and Forecast, by Equipment
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.4 Netherlands Market Size and Forecast, by Application
      • 16.3.14.5 Netherlands Market Size and Forecast, by End User
      • 16.3.14.6 Netherlands Market Size and Forecast, by Form
      • 16.3.14.7 Netherlands Market Size and Forecast, by Process
      • 16.3.14.8 Netherlands Market Size and Forecast, by Installation Type
      • 16.3.14.9 Netherlands Market Size and Forecast, by Equipment
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Technology
      • 16.3.15.4 Sweden Market Size and Forecast, by Application
      • 16.3.15.5 Sweden Market Size and Forecast, by End User
      • 16.3.15.6 Sweden Market Size and Forecast, by Form
      • 16.3.15.7 Sweden Market Size and Forecast, by Process
      • 16.3.15.8 Sweden Market Size and Forecast, by Installation Type
      • 16.3.15.9 Sweden Market Size and Forecast, by Equipment
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.4 Switzerland Market Size and Forecast, by Application
      • 16.3.16.5 Switzerland Market Size and Forecast, by End User
      • 16.3.16.6 Switzerland Market Size and Forecast, by Form
      • 16.3.16.7 Switzerland Market Size and Forecast, by Process
      • 16.3.16.8 Switzerland Market Size and Forecast, by Installation Type
      • 16.3.16.9 Switzerland Market Size and Forecast, by Equipment
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Technology
      • 16.3.17.4 Denmark Market Size and Forecast, by Application
      • 16.3.17.5 Denmark Market Size and Forecast, by End User
      • 16.3.17.6 Denmark Market Size and Forecast, by Form
      • 16.3.17.7 Denmark Market Size and Forecast, by Process
      • 16.3.17.8 Denmark Market Size and Forecast, by Installation Type
      • 16.3.17.9 Denmark Market Size and Forecast, by Equipment
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Technology
      • 16.3.18.4 Finland Market Size and Forecast, by Application
      • 16.3.18.5 Finland Market Size and Forecast, by End User
      • 16.3.18.6 Finland Market Size and Forecast, by Form
      • 16.3.18.7 Finland Market Size and Forecast, by Process
      • 16.3.18.8 Finland Market Size and Forecast, by Installation Type
      • 16.3.18.9 Finland Market Size and Forecast, by Equipment
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Technology
      • 16.3.19.4 Russia Market Size and Forecast, by Application
      • 16.3.19.5 Russia Market Size and Forecast, by End User
      • 16.3.19.6 Russia Market Size and Forecast, by Form
      • 16.3.19.7 Russia Market Size and Forecast, by Process
      • 16.3.19.8 Russia Market Size and Forecast, by Installation Type
      • 16.3.19.9 Russia Market Size and Forecast, by Equipment
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Form
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Installation Type
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Equipment
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Form
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Installation Type
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Equipment
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Technology
      • 16.4.9.4 China Market Size and Forecast, by Application
      • 16.4.9.5 China Market Size and Forecast, by End User
      • 16.4.9.6 China Market Size and Forecast, by Form
      • 16.4.9.7 China Market Size and Forecast, by Process
      • 16.4.9.8 China Market Size and Forecast, by Installation Type
      • 16.4.9.9 China Market Size and Forecast, by Equipment
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Technology
      • 16.4.10.4 India Market Size and Forecast, by Application
      • 16.4.10.5 India Market Size and Forecast, by End User
      • 16.4.10.6 India Market Size and Forecast, by Form
      • 16.4.10.7 India Market Size and Forecast, by Process
      • 16.4.10.8 India Market Size and Forecast, by Installation Type
      • 16.4.10.9 India Market Size and Forecast, by Equipment
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Technology
      • 16.4.11.4 Japan Market Size and Forecast, by Application
      • 16.4.11.5 Japan Market Size and Forecast, by End User
      • 16.4.11.6 Japan Market Size and Forecast, by Form
      • 16.4.11.7 Japan Market Size and Forecast, by Process
      • 16.4.11.8 Japan Market Size and Forecast, by Installation Type
      • 16.4.11.9 Japan Market Size and Forecast, by Equipment
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Technology
      • 16.4.12.4 South Korea Market Size and Forecast, by Application
      • 16.4.12.5 South Korea Market Size and Forecast, by End User
      • 16.4.12.6 South Korea Market Size and Forecast, by Form
      • 16.4.12.7 South Korea Market Size and Forecast, by Process
      • 16.4.12.8 South Korea Market Size and Forecast, by Installation Type
      • 16.4.12.9 South Korea Market Size and Forecast, by Equipment
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Technology
      • 16.4.13.4 Australia Market Size and Forecast, by Application
      • 16.4.13.5 Australia Market Size and Forecast, by End User
      • 16.4.13.6 Australia Market Size and Forecast, by Form
      • 16.4.13.7 Australia Market Size and Forecast, by Process
      • 16.4.13.8 Australia Market Size and Forecast, by Installation Type
      • 16.4.13.9 Australia Market Size and Forecast, by Equipment
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Technology
      • 16.4.14.4 Singapore Market Size and Forecast, by Application
      • 16.4.14.5 Singapore Market Size and Forecast, by End User
      • 16.4.14.6 Singapore Market Size and Forecast, by Form
      • 16.4.14.7 Singapore Market Size and Forecast, by Process
      • 16.4.14.8 Singapore Market Size and Forecast, by Installation Type
      • 16.4.14.9 Singapore Market Size and Forecast, by Equipment
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.4 Indonesia Market Size and Forecast, by Application
      • 16.4.15.5 Indonesia Market Size and Forecast, by End User
      • 16.4.15.6 Indonesia Market Size and Forecast, by Form
      • 16.4.15.7 Indonesia Market Size and Forecast, by Process
      • 16.4.15.8 Indonesia Market Size and Forecast, by Installation Type
      • 16.4.15.9 Indonesia Market Size and Forecast, by Equipment
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.4 Taiwan Market Size and Forecast, by Application
      • 16.4.16.5 Taiwan Market Size and Forecast, by End User
      • 16.4.16.6 Taiwan Market Size and Forecast, by Form
      • 16.4.16.7 Taiwan Market Size and Forecast, by Process
      • 16.4.16.8 Taiwan Market Size and Forecast, by Installation Type
      • 16.4.16.9 Taiwan Market Size and Forecast, by Equipment
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.4 Malaysia Market Size and Forecast, by Application
      • 16.4.17.5 Malaysia Market Size and Forecast, by End User
      • 16.4.17.6 Malaysia Market Size and Forecast, by Form
      • 16.4.17.7 Malaysia Market Size and Forecast, by Process
      • 16.4.17.8 Malaysia Market Size and Forecast, by Installation Type
      • 16.4.17.9 Malaysia Market Size and Forecast, by Equipment
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Installation Type
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Equipment
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Technology
    • 16.5.5 Latin America Market Size and Forecast, by Application
    • 16.5.6 Latin America Market Size and Forecast, by End User
    • 16.5.7 Latin America Market Size and Forecast, by Form
    • 16.5.8 Latin America Market Size and Forecast, by Process
    • 16.5.9 Latin America Market Size and Forecast, by Installation Type
    • 16.5.10 Latin America Market Size and Forecast, by Equipment
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Technology
      • 16.5.9.4 Brazil Market Size and Forecast, by Application
      • 16.5.9.5 Brazil Market Size and Forecast, by End User
      • 16.5.9.6 Brazil Market Size and Forecast, by Form
      • 16.5.9.7 Brazil Market Size and Forecast, by Process
      • 16.5.9.8 Brazil Market Size and Forecast, by Installation Type
      • 16.5.9.9 Brazil Market Size and Forecast, by Equipment
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Technology
      • 16.5.10.4 Mexico Market Size and Forecast, by Application
      • 16.5.10.5 Mexico Market Size and Forecast, by End User
      • 16.5.10.6 Mexico Market Size and Forecast, by Form
      • 16.5.10.7 Mexico Market Size and Forecast, by Process
      • 16.5.10.8 Mexico Market Size and Forecast, by Installation Type
      • 16.5.10.9 Mexico Market Size and Forecast, by Equipment
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Technology
      • 16.5.11.4 Argentina Market Size and Forecast, by Application
      • 16.5.11.5 Argentina Market Size and Forecast, by End User
      • 16.5.11.6 Argentina Market Size and Forecast, by Form
      • 16.5.11.7 Argentina Market Size and Forecast, by Process
      • 16.5.11.8 Argentina Market Size and Forecast, by Installation Type
      • 16.5.11.9 Argentina Market Size and Forecast, by Equipment
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Form
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Installation Type
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Equipment
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Form
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Installation Type
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Equipment
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Form
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Installation Type
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Equipment
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Technology
      • 16.6.10.4 UAE Market Size and Forecast, by Application
      • 16.6.10.5 UAE Market Size and Forecast, by End User
      • 16.6.10.6 UAE Market Size and Forecast, by Form
      • 16.6.10.7 UAE Market Size and Forecast, by Process
      • 16.6.10.8 UAE Market Size and Forecast, by Installation Type
      • 16.6.10.9 UAE Market Size and Forecast, by Equipment
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Technology
      • 16.6.11.4 South Africa Market Size and Forecast, by Application
      • 16.6.11.5 South Africa Market Size and Forecast, by End User
      • 16.6.11.6 South Africa Market Size and Forecast, by Form
      • 16.6.11.7 South Africa Market Size and Forecast, by Process
      • 16.6.11.8 South Africa Market Size and Forecast, by Installation Type
      • 16.6.11.9 South Africa Market Size and Forecast, by Equipment
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Form
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Installation Type
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Equipment
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 QuidelOrtho
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Bio-Rad Laboratories
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Cepheid
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 BioMerieux
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Hologic
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Roche Diagnostics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Abbott Laboratories
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Siemens Healthineers
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Thermo Fisher Scientific
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Sysmex Corporation
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Ortho Clinical Diagnostics
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Beckman Coulter
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Nova Biomedical
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Alere
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Randox Laboratories
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
  • 18.16 Sekisui Diagnostics
    • 18.16.1 Company Overview
    • 18.16.2 Company Snapshot
    • 18.16.3 Business Segments
    • 18.16.4 Business Performance
    • 18.16.5 Product Offerings
    • 18.16.6 Key Developmental Strategies
    • 18.16.7 SWOT Analysis
  • 18.17 Trinity Biotech
    • 18.17.1 Company Overview
    • 18.17.2 Company Snapshot
    • 18.17.3 Business Segments
    • 18.17.4 Business Performance
    • 18.17.5 Product Offerings
    • 18.17.6 Key Developmental Strategies
    • 18.17.7 SWOT Analysis
  • 18.18 Meridian Bioscience
    • 18.18.1 Company Overview
    • 18.18.2 Company Snapshot
    • 18.18.3 Business Segments
    • 18.18.4 Business Performance
    • 18.18.5 Product Offerings
    • 18.18.6 Key Developmental Strategies
    • 18.18.7 SWOT Analysis
  • 18.19 EKF Diagnostics
    • 18.19.1 Company Overview
    • 18.19.2 Company Snapshot
    • 18.19.3 Business Segments
    • 18.19.4 Business Performance
    • 18.19.5 Product Offerings
    • 18.19.6 Key Developmental Strategies
    • 18.19.7 SWOT Analysis
  • 18.20 Luminex Corporation
    • 18.20.1 Company Overview
    • 18.20.2 Company Snapshot
    • 18.20.3 Business Segments
    • 18.20.4 Business Performance
    • 18.20.5 Product Offerings
    • 18.20.6 Key Developmental Strategies
    • 18.20.7 SWOT Analysis